Literature DB >> 71024

B lymphocyte alloantigens in the study of the genetic basis of rheumatoid arthritis.

G S Panayi, P H Wooley.   

Abstract

In order to carry out tissue typing studies in patients with rheumatoid arthritis (RA), 116 sera from pregnant multiparous women were screened for cytotoxicity specific for B lymphocytes. It was possible to identify three sera (M55, M58, M87) which reacted specifically with B cells after absorption with platelets. Each appeared to have a different specificity which was presumed to correspond to an alloantigen marker on the lymphocyte surface. The frequency of these alloantigen markers on B lymphocytes was investigated in patients with classical or definite RA and in controls. One of these, M58, occurred in 32 out of 43 RA patients (74 - 4%) compared with 10 out of 37 controls (27%). This difference was highly significant (P less than 0 - 0005). The relative risk of developing RA is 7 - 85 times greater in those possessing alloantigen M58. The other two B cell alloantigens failed to show any association with RA. The association with M58 may indicate a significant genetic contribution to disease susceptibility in RA.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 71024      PMCID: PMC1006699          DOI: 10.1136/ard.36.4.365

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  12 in total

1.  DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.

Authors: 
Journal:  Ann Rheum Dis       Date:  1959-03       Impact factor: 19.103

2.  Mixed leukocyte reaction (MLR) in rheumatoid arthritis: dose-response kinetics.

Authors:  E C Keystone; D D Gladman; M B Urowitz; D A Clarke
Journal:  Clin Immunol Immunopathol       Date:  1976-05

3.  Ankylosing spondylitis and HL-A 27.

Authors:  D A Brewerton; F D Hart; A Nicholls; M Caffrey; D C James; R D Sturrock
Journal:  Lancet       Date:  1973-04-28       Impact factor: 79.321

4.  Histocompatibility antigens and rheumatoid arthritis.

Authors:  R B Lies; R P Messner; G M Troup
Journal:  Arthritis Rheum       Date:  1972 Sep-Oct

5.  HL-A antigens in rheumatoid arthritis.

Authors:  J Seignalet; J Clot; J Sany; H Serre
Journal:  Vox Sang       Date:  1972       Impact factor: 2.144

6.  Altered reactivity in mixed lymphocyte culture of lymphocytes from patients with rheumatoid arthritis.

Authors:  G P Astorga; R C Williams
Journal:  Arthritis Rheum       Date:  1969-12

7.  Multiple sclerosis and high incidence of a B lymphocyte antigen.

Authors:  P I Terasaki; M S Park; G Opelz; A Ting
Journal:  Science       Date:  1976-09-24       Impact factor: 47.728

8.  HL-A27 and arthritis.

Authors:  H Isomäki; K Koota; J Martio; M Nissilä; A Tilikainen
Journal:  Ann Clin Res       Date:  1975-06

9.  New lymphocyte antigen system (Lna) controlled by the Ir region of the mouse H-2 complex.

Authors:  C S David; D C Shreffler; J A Frelinger
Journal:  Proc Natl Acad Sci U S A       Date:  1973-09       Impact factor: 11.205

10.  Recognition by pregnancy serums of non-HL-A alloantigens selectively expressed on B lymphocytes.

Authors:  R J Winchester; P Wernet; H G Kunkel; B Dupont; C Jersild; S M Fu
Journal:  J Exp Med       Date:  1975-04-01       Impact factor: 14.307

View more
  9 in total

1.  Association of HLA-B35 with mucocutaneous lesions in Israeli patients with rheumatoid arthritis receiving gold treatment.

Authors:  M Tishler; D Caspi; E Gazit; M Yaron
Journal:  Ann Rheum Dis       Date:  1988-03       Impact factor: 19.103

2.  Immunopharmacological control of inflammation.

Authors:  P Dukor
Journal:  Ann R Coll Surg Engl       Date:  1978-05       Impact factor: 1.891

3.  Genetic aspects of rheumatoid arthritis.

Authors:  R J Winchester
Journal:  Springer Semin Immunopathol       Date:  1981

4.  HLA-DR genotype risks in seropositive rheumatoid arthritis.

Authors:  L Legrand; G M Lathrop; A Marcelli-Barge; A Dryll; T Bardin; N Debeyre; J C Poirier; M Schmid; A Ryckewaert; J Dausset
Journal:  Am J Hum Genet       Date:  1984-05       Impact factor: 11.025

5.  HLA haplotypes in non-familial rheumatoid arthritis.

Authors:  L Legrand; G M Lathrop; T Bardin; A Marcelli-Barge; A Dryll; N Debeyre; A Ryckewaert
Journal:  Ann Rheum Dis       Date:  1987-05       Impact factor: 19.103

6.  HLA studies in IgM rheumatoid-factor-positive arthritis of childhood.

Authors:  L E Clemens; E Albert; B M Ansell
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

Review 7.  Rheumatoid arthritis and Proteus: a possible aetiological association.

Authors:  A Ebringer; S Khalafpour; C Wilson
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

8.  Studies of lymphocytes in rheumatoid arthritis. I. Uptake of 125I-heat aggregated human IgG by Fc-receptor bearing lymphocytes.

Authors:  P H Wooley; G S Panayi
Journal:  Ann Rheum Dis       Date:  1978-08       Impact factor: 19.103

9.  Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs.

Authors:  G S Panayi; P Wooley; J R Batchelor
Journal:  Br Med J       Date:  1978-11-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.